Status:
COMPLETED
Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation
Lead Sponsor:
Karolinska Institutet
Conditions:
ADHD Predominantly Inattentive Type
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Using a randomized controlled design, standard treatment of group cognitive-behavioral therapy (CBT) according to the Hesslinger protocol is compared to a newly developed group treatment specifically ...
Eligibility Criteria
Inclusion
- Principal diagnosis of ADHD inattentive presentation
- 18 years of age or older
- If on medication, it needs to be well-established since three months, and
- Prior psycho-educational intervention
Exclusion
- Intellectual impairment
- Substance use disorder
- Difficulties in adherence to medical or other treatment
- Social and/or psychiatric problems to such an extent that they prevent focusing on treatment, or
- Simultaneous psychological treatment
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04090983
Start Date
September 1 2019
End Date
December 31 2024
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatry Centre Södertälje
Södertälje, Stockholm County, Sweden, 15240